维普中文期刊产品整合服务
27篇 您的检索式:作者名="Sherchan"
    题名 作者 年代 出处 被引量
1Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice显示文摘ALTAY O HASEGAWA Y SHERCHAN P 2012Crit Care Med2012,40,:1
2Controversies and Evolving New Mechanisms in Subarachnoid Hemorrhage 显示文摘Chen S Feng H Sherchan P 2014Progress in neurobiology2014,115,:1
3Controversies and evolving new mechanisms in subarachnoid hemorrhage 显示文摘Sheng Chen Hua Feng Prativa Sherchan 2014Progress in Neurobiology2014,115,:1
4Cannabinoid receptor type 2 agonist attenuates acute neurogenic pulmonary edema by prevent- ing neutrophil migration after subaraehnoid hemorrhage in rats 显示文摘Fujii M Sherchan P Soejima Y 2016Aeta Neuroehir Suppl2016,121,:1
5Synthesis, cytotoxicity and structure-activity relationship study of terpyridines显示文摘Zhao L Sherchan J Park J K 2006Arch Pharmacol Res2006,29,12:1
6Surgical brain injury and edema prevention 显示文摘Sherchan P Kim CH Zhang JH 2013ActaNeurochir Suppl2013,118,:1
7Assessing placement of nasoduodenal tube its usefulness in maintaining nutrition in critically ill patients显示文摘Nayak S K Sherchan M 2008Nepal Med Coll J2008,10,4:1
8Tyrosine phos- phatase inhibition attenuates early brain injury after sub- arachnoid hemorrhage in rats显示文摘Hasegawa Y Suzuki H Sherchan P 2011Acta Neurochir Suppl2011,110,1:1
9Minocyefine improves functional outcomes, memory deficits, and histopathology after endovaseular perforation-induced subarachnoid hemorrhage in rats 显示文摘Sherchan P Lekic T Suzuki H 2011J Neurotrauma2011,28,12:1
10Controversies and evolving new mechanisms in subarachnoid hemorrhage 显示文摘Chert S Feng H Sherchan P 2014Prog Neurobiol2014,115,:1
11Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphory- lated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats 显示文摘Fujii M Sherchan P Soejima Y 2014Exp Neurol2014,261,:1
12Intravas- cular catheter-related infections in an Indian tertiary care hospital显示文摘Parameswaran R Sherchan JB Varma DM 2011J lnfect Dev Ctries2011,5,6:1
13Intravas- cular catheter-related infections in an Indian tertiary care hospital显示文摘Parameswaran R Sherchan JB Varma DM 2011J lnfect Dev Ctries2011,5,6:1
14Controversies and evolving new mechanisms in subarachnoid hemorrhage显示文摘Chen S Feng H Sherchan P 2014Progress Neurobiol2014,115,:1
15Controversies and evolving new mechanisms in subarachnoid hemorrhage显示文摘Chen S Feng H Sherchan P et aI 2014Prog Neuro- biol2014,115,:1
16Assessing placement of nasoduodenal tube and its usefulness in maintaining nutrition in critically ill patients显示文摘Nayak SK Sherchan M Durra Poudel S 2008Nepal Med Coll J2008,10,4:1
17Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses显示文摘BACKGROUND Immune checkpoint inhibitors(ICPi)cause various immune-related adverse events(irAE)with thyroid dysfunction as a commonly reported abnormality.There is increasing evidence showing positive association with development of irAE and survival.However,prior trials with ICPi had underrepresentation of minorities with<5%African Americans.AIM To evaluate the association between development of irAE and survival outcomes among a racially diverse patient population.METHODS Data on patients with stage IV solid malignancies treated with programmed cell death-protein 1/programmed death ligand 1 blockers between January 2013 and December 2018 across MedStar Georgetown Cancer Institute facilities were retrospectively reviewed.Patients treated with cytotoxic T-lymphocyte-associated protein 4 inhibitors were excluded.Progression free survival(PFS)and overall survival(OS)were primary endpoints and were calculated using Kaplan-Meier methods and Wilcoxon rank sum test for comparison.RESULTS Out of 293 patients who met eligibility criteria,91 pts(31%)had any grade irAE;most common AE were endocrine(40.7%)specifically TSH elevation,dermatological(23.1%)and rheumatologic(18.7%).Proportion of irAE was significantly higher in Caucasians vs African Americans(60.4%vs 30.8%),in patients with low programmed death ligand 1,lower LDH,older age,and those who had more treatment cycles with ICPi.Rate of progression was lower in patients with irAE(30.8%vs 46.0%,P=0.0140).Median PFS(5.8 vs 3.0 mo,P=0.0204)and OS(17.1 vs 7.2 mo,P<0.0001)were higher with irAE.Statistically significant difference in OS(17.1 vs 8.6 mo,P=0.0002)but not in PFS(5.8 vs 3.3 mo,P=0.0545)was noted with endocrine irAE.No differences in survival were observed among other commonly reported irAE.Differences in survival among subgroups of patients with irAE are described.CONCLUSION Development of irAE positively correlated with improved PFS and OS as reported in previous studies.To our knowledge,this is the first study observing differences in OS favoring endocrine AE and Caucasian race.These factors may be potential surrogate markers of prognosis pending replication of these results in large-scale studies.Monica Peravali Cristiane Gomes-Lima Eshetu Tefera Mairead Baker Mamta Sherchan Saira Farid Kenneth Burman Florina Constantinescu Irina Veytsman 2021World Journal of Clinical Oncology2021,12,2:1
18A survey of trust in social networks显示文摘SHERCHAN W NEPAL S PARIS C 2013ACM Computing Surveys2013,45,4:1
19A survey of trust in social networks 显示文摘SHERCHAN W NEPAL S PARIS C 2013ACM Computing Sur- veys2013,45,4:1
20Controversies and e- volving new mechanisms in subarachnoid hernorrhage显示文摘Chen S Feng H Sherchan P et aI 2014Prog Neurobiol2014,115,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费